International Companies

Generic competition hits Q1 earnings at Novartis

By Abigail Townsend

Date: Tuesday 28 Apr 2026

(Sharecast News) - Shares in Novartis came under pressure on Tuesday, after quarterly numbers from the Swiss pharmaceutical firm disappointed.
Net sales declined by 5%, or 1% on a constant currency basis, in the first three months of the year to $13.1bn, hit by generic competition in the US and narrowly...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page